MAPK3 and neoplasm: ACTN1, upregulated in OC and linked to poor prognosis, promotes tumor growth, EMT, and M2 macrophage polarization via ERK1/2 signaling; FBXO25 interacts upstream, and ERK1/2 inhibition partially reverses these effects.